The Lancet Oncology · 2013 · 576 citations · 27 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyNeoplasiaLung CancerMalignant NeoplasmsTumor BiologyAlk Fusion GenesAlk Point MutationsAnaplastic Lymphoma Kinase InhibitorsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment
27
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Manabu Soda, Young Lim Choi, Munehiro Enomoto et al. · Nature · 2007 · 5.4K citations
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge et al. · New England Journal of Medicine · 2010 · 4.5K citations
Medicine, Oncology, Pharmacology +14
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
Kristin Bergethon, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2012 · 1.6K citations · Full text